Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zvonimir L Milas

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Oral and Maxillofacial Surgery Clinics of North America|September 30, 2018
Getting It Right from the StartZvonimir L Milas, Thomas D Shellenberger
Oral and Maxillofacial Surgery Clinics of North America|November 20, 2018
The Head and Neck Cancer Patient: Neoplasm ManagementZvonimir L Milas, Thomas D Shellenberger
The American Surgeon|May 26, 2004
Pediatric blunt trauma resulting in major arterial injuriesZvonimir L Milas, Thomas F Dodson, Richard R Ricketts
Journal of Pediatric Surgery|May 9, 2006
Endograft stenting in the adolescent population for traumatic aortic injuriesZvonimir L Milas, Ross Milner, Elliot Chaikoff, et al.
The Laryngoscope|November 20, 2023
Enhanced Recovery After Surgery and Perioperative Laryngectomy OutcomesCatherine H Frenkel, Erin E Donahue, Daniel Brickman, et al.
Head & Neck|September 11, 2014
Well-differentiated thyroid cancer with aerodigestive tract invasion: Long-term control and functional outcomesShirley Y Su, Zvonimir L Milas, Neel Bhatt, et al.
American Journal of Clinical Oncology|April 13, 2012
Poly (ADP-ribose) polymerase inhibitors in cancer treatmentKathryn A Mason, Uma Raju, Thomas A Buchholz, et al.
Head & Neck|July 29, 2024
The impact of an enhanced recovery after surgery protocol for major head and neck oncologic surgery on postoperative complications and adjuvant treatment deliveryCatherine H Frenkel, Erin E Donahue, Allyson Cochran, et al.
Laryngoscope Investigative Otolaryngology|December 22, 2022
Defining targets to improve care delivery for T4 larynx squamous cell carcinomaCatherine H Frenkel, Daniel S Brickman, Sally J Trufan, et al.
Head & Neck|July 15, 2010
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse modelDaisuke Sano, David R Fooshee, Mei Zhao, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Oral and Maxillofacial Surgery Clinics of North America|September 30, 2018
Getting It Right from the StartZvonimir L Milas, Thomas D Shellenberger
Oral and Maxillofacial Surgery Clinics of North America|November 20, 2018
The Head and Neck Cancer Patient: Neoplasm ManagementZvonimir L Milas, Thomas D Shellenberger
The American Surgeon|May 26, 2004
Pediatric blunt trauma resulting in major arterial injuriesZvonimir L Milas, Thomas F Dodson, Richard R Ricketts
Journal of Pediatric Surgery|May 9, 2006
Endograft stenting in the adolescent population for traumatic aortic injuriesZvonimir L Milas, Ross Milner, Elliot Chaikoff, et al.
The Laryngoscope|November 20, 2023
Enhanced Recovery After Surgery and Perioperative Laryngectomy OutcomesCatherine H Frenkel, Erin E Donahue, Daniel Brickman, et al.
Head & Neck|September 11, 2014
Well-differentiated thyroid cancer with aerodigestive tract invasion: Long-term control and functional outcomesShirley Y Su, Zvonimir L Milas, Neel Bhatt, et al.
American Journal of Clinical Oncology|April 13, 2012
Poly (ADP-ribose) polymerase inhibitors in cancer treatmentKathryn A Mason, Uma Raju, Thomas A Buchholz, et al.
Head & Neck|July 29, 2024
The impact of an enhanced recovery after surgery protocol for major head and neck oncologic surgery on postoperative complications and adjuvant treatment deliveryCatherine H Frenkel, Erin E Donahue, Allyson Cochran, et al.
Laryngoscope Investigative Otolaryngology|December 22, 2022
Defining targets to improve care delivery for T4 larynx squamous cell carcinomaCatherine H Frenkel, Daniel S Brickman, Sally J Trufan, et al.
Head & Neck|July 15, 2010
Targeted molecular therapy of head and neck squamous cell carcinoma with the tyrosine kinase inhibitor vandetanib in a mouse modelDaisuke Sano, David R Fooshee, Mei Zhao, et al.
Pageof 3